InvestorsHub Logo

ziploc_1

09/04/20 4:51 PM

#296438 RE: alm2 #296415

Alms...I agree...Why not cut expenses and deal from strength while awaiting a legitimate BO offer?...The additional revenues will not make up for the expenses of supporting a team of 800 reps, especially with the Generics standing by in the wings....A profitable Amarin will attract better buying interests..Later on, Amarin or whatever company owns it can sell Vascepa OTC.